Skip to main content

Table 3 miRNAs differentially expressed in early (I and II) vs late stage (III and IV) disease.

From: Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer

Sample ID

Stage I/II

Stage III/IV

Fold change

p-value

hsa-miR-31

7.11

9.97

7.22

1.53E-03

hsa-miR-7

7.77

8.85

2.11

1.96E-02

hsa-miR-99b

8.74

8.12

0.65

3.64E-03

hsa-miR-378*

6.85

6.23

0.65

3.02E-02

hsa-miR-133a

7.64

6.96

0.63

1.64E-02

hsa-miR-125a

10.64

9.76

0.54

2.69E-03

  1. Fold change = Stage III/IV:Stage I/II
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us